A little about Gadolinium
A large and growing community of patients in search of Information or living with Adverse Events
Hundreds of new members join worldwide support groups every single month.
In search of answers ---
- their doctor ordered diagnostic imaging for an ailment and prescribed a Gadolinium-Based Contrast Agent (GBCA) and they are seeking and doing their due diligence to learn more.
- they've had an injection and find themselves experiencing new, worsening, unexpected and unexplainable health concerns that may have NOTHING to do with the original aliment or reason they sought imaging.
Patients who join the support groups often state
- they were NEVER afforded a Medication Guide, a consult, documentation that outlined the known risks.
- they are told contrast is the ONLY option.
GAPS exist today - for a variety of reasons.
What is Gadolinium and how is it used
Gadolinium is a versatile rare-earth metal. It's uses include -
- Electronics and Technology: Gadolinium compounds are used in computer memory, optical fibers, and compact discs.
- Industrial Alloys & Magnets: It is used in high-temperature alloys (iron/chromium) for aircraft engines and gas turbines to improve durability and oxidation resistance. It is also used in high-performance magnets.
- Magnetic Refrigeration: Due to its strong magnetocaloric effect, it is used in experimental, near-room-temperature magnetic refrigerators.
- Medical Imaging (MRI): Gadolinium-based contrast agents (GBCAs) are injected into patients to significantly enhance the contrast in MRI scans, assisting in the diagnosis of tumors, cancer, and neurological disorders. It is important to note that for medical use, gadolinium must be safely trapped inside a chelating agent to prevent toxicity, as free gadolinium ions are harmful.
- Nuclear Power: Because it possesses a very high nuclear neutron absorption cross-section, gadolinium is used to control reactions in nuclear reactors and as a burnable poison.
- Phosphors and Imaging: It acts as a green phosphor in X-ray intensifying screens and in older color television tubes.
Source: ChatGDP 2/9/2025
Medical Imaging (MRI) and the use of Gadolinium-Based Contrast Agents
Gadolinium-Based Contrast Agents (GBCAs) are used in Diagnostic Magnetic Resonance Imaging.
Gadolinium serves no biological reason or physiological reason to be found in the human body.
- GBCAs - active ingredient is Gadolinium, regardless of brand. The agent is wrapped in a ligand, intended to make it safe.
- Once thought to be safe; now science and research continues to build - health issues are of concern.
- Nephrogenic Systemic Fibrosis (NSF) was the first formal diagnosis, in 1997, and at the time thought to impact only patients with kidney issues. That dialogue has since been updated after it was recognized that kidney injury/damage was no longer applicable. The term most often applied today - Gadolinium Iatrogenic Fibrosis, which can be found in the connective tissue and/or any organ in the human body.
- In 2018, the manufacturers signed a letter acknowledging some amount is retained in everyone injected, for months to years. Found in the brain, bones, tissue, and organs.
- Gadolinium is the same size molecule as Calcium and is a known calcium-channel blocker.
- After decades of use and over half-billion injections --- these agents are still injected tens-of-millions of times annually.
- Currently there is no formal process for following patients 1, 3, 5, 10 years after injection to monitor or track possible changes in health status. This is problematic as patients report retained gadolinium in their blood serum, hair, urine and hair years later. Gaps in the RACI (Responsible, Accountable, Communicated, Informed) protocols, processes exist today.
- There is NO FDA approved antidote or cure to safely, effectively, efficiently eradiate this toxicant out of the human body once it has been injected.
#InformedConsent, #Truth, #Transparency about known risks, concerns is a MUST and impacts patient confidence, which continues to wane as patients are often gaslit, bullied, shamed and left to self-triage issues when they occur - Gaps exist today!
Patients simply want to feel better and are unheard - even when arriving with with new questions/concerns and testing in hand.
All of this is well documented and yet patients continue to say they are very often unable to find medical resources willing to have a conversation or open dialogue. A large reason sites like this exist.
This Site is dedicated to ...
- To those who are suffering or have lost their lives from complications related to retained Gadolinium.
- To those past, present and future for - standing, being a voice, showing support even while searching for answers.
Dedication and efforts such as these are
Not for Naught.
About The passion and purpose
A little about how Living with Gadolinium, LLC came about.
Thank you for visiting!
I'm Debbie - here's a little about my personal gadolinium journey.
Before 2016, I was healthy and very active, loving all things outdoors.
From 2016-18, I suffered multiple pancreatitis episodes, requiring me to spend several days in the hospital each time.
What I didn't know at the time was that each time they did an MRI with a GBCA (Gadolinium-Based Contrast Agent) my body was being poisoned and left retaining and accumulating amounts of the Gadolinium.
I was never given a consultation or information about the fact that Gadolinium is Toxic to humans, nor was I asked about giving "Informed consent" before being injected.
In May 2018, the manufacturers sent out a letter that, in part, acknowledged some amount of Gadolinium is retained in everyone, in the brain, bones, tissue, and organs. During that time, thanks to a group of patient advocates, the FDA updated Gadolinium with Box Warnings and asked that all Medication Guides be updated. In the FDA meeting, it was communicated - anyone receiving an MRI with Contrast should receive a copy of the medication guide and an opportunity to give informed consent or decline contrast.
In 2023, data was submitted and ICD-10 billing code were approved.
The information package presented wad intended to give more clarity about Gadolinium Toxicity. In part, the statement included in the package states -
"Gadolinium toxicity has the potential to cause disease in humans, and even in small amounts may be associated with significant morbidity and mortality. Gadolinium Toxicity can affect many body systems including the musculoskeletal, brain, skin, renal, and neurologic systems."
Cite - Diagnosis Agenda. Topic Packet. 2022-03-08-ICD-10-PCS-CM-Meeting-Materials |
CMS. Source: cdc.gov. https://www.cdc.gov/nchs/data/icd/march-2022-topic-packetfinal.
1.pdf (pages 37- 38)
Today, so much scientific published research exists --
So much has come to light since I was first poisoned; we've learned a lot. I've learned a lot.
After I was poisoned with Gadolinium, I began searching and learning answers, such as -
- Gadolinium, a rare earth metal, is TOXIC to humans - it serves no biological reason to be found in the human body.
- Some amount of Gadolinium is retained in everyone who receives an MRI/MRA with contrast.
- There is no FDA-approved cure or antidote for Gadolinium.
- There are multiple worldwide support groups and websites available to help patients learn about this toxic man-induced poison.
- Healthcare continues to inject this drug and toxic metal tens of millions of times annually (depending on who you ask)
If you are here, you may be struggling with Gadolinium retention, or perhaps you are just here out of curiosity to learn more. There are several files and links in the Resource section of this site that we hope will be helpful to you.
After connecting the dots in new ways that suddenly made sense to why I was suddenly sicker than imaginable following my own personal experiences with a GBCA (gadolinium-based contrast agent), I had an NDE (near death experience). From that day forward, my heart has been led to find ways to heal my body while at the same time be there in ways that might help others with similar experiences - connect the dots, understand, and know they are not alone.
Gadolinium has been an incredible and more often than not - challenging journey.
May the power of storytelling of the very real and personal stories afford -
- New awareness about this drug.
- Patients are left to triage and find answers to questions about their own changing health concerns, as they seek to learn, find helpful resources, and heal.
- New and open dialogue - each of us having a seat at the table to figure this out.
- Partnerships with a seat at the table for everyone are formed.
- Change in positive ways be manifested.
Gadolinium changes our DNA, our health, and our relationships. Through sharing and being open about our experiences, it is my hope and that of many that patients feel empowered, while the FDA and medical communities gather information to help us.
#askquestions, #beaware, #itsyourbody, #advocate4you, #gadoliniumtoxicity, #gadoliniumdepositiondisea
God has gifted me, and I am blessed. All the glory is His. This continues to be an incredible journey - filled with many lessons and blessings. My heart is filled with gratitude to all those I have met.
Blessing to each of you reading this, never give up - whatever your struggle.
In kindness,
Debbie Heist Lambert
Living with Gadolinium, LLC
This image, a handmade card from my granddaughter - to encourage me to feel better soon.
A list of medical diagnoses
A list of medical diagnoses following four injections of Gadolinium-Based Contrast Agents
Debbie Heist Lambert – Ongoing List of Issues, Testing, and Diagnoses.
This list includes issues, testing, and diagnoses from April 2018 – 2025.
July 2025 - Testing at the University of New Mexico - results show high levels of Gadolinium in Blood Serum, Finger Nails, Hair, and Urine.
- Last GBCA injection 2018.
- Amyloidosis* (testing inconclusive, monitor/biopsy required)
- Anaphylaxis*
- Anhidrosis
- B12 and Folate deficiency
- Bone pain, muscle wasting and weakness noted by several doctors
- Chronic inflammation—face swollen and puffy, stomach ascended as if my organs no longer fit in my body, hands, and feet on fire, skin itchy, hair falling out, weight loss
- Dental, more than $14,000 invested since gadolinium injections. Results 6-tooth-bridge, loss of several teeth
- Double vision, ocular migraines, floaters, peripheral hallucinations*
- Drug-induced dementia (2018 cognitive testing showed four areas of the brain impacted, brain MRI showed no sign of Alzheimer's)
- EBV (Epstein-Barr virus)*
- Fibromyalgia
- Frozen shoulder (Ultrasound showing calcifications which were blasted and removed)
- Gallbladder - removed 2018
- Hashimoto's (for 25+ years)—new, worsening issues* with tumor and nodule diagnosis in September 2022. (Thyroid, pituitary, or both? I declined the offer for nuclear and contrasted imaging.)
- Heart – Hypertrophic Myocarditis, SVT - (supraventricular tachycardia), Bradycardia, low pulse
- Histamine allergies following the placement of a six-tooth zirconium bridge*
- Kidneys – July 05, 2023 – normal size symmetric cortical enhancement, middle right-sided hydronephrosis with narrowing at the right UPJ (stenosis?).
2025 April US – Right pelvic dilation 1.6cm (noticed on July 2023), right and left – small punctate calcifications throughout the renal cortex. Etiologies, including medullary nephrocalcinosis, nephrolithiasis, etc., should be considered. No hydronephrosis.
- Liver – initial testing/diagnosis Fatty Liver, July 2023, normal size, 2025 April US – Liver enlarged – 18.3 cm with increased echogenicity)
- Lungs - x-ray/ultrasound suggest signs of pulmonary fibrosis - 2025. Additional tests scheduled in February 2026
- Lupus*
- Mast cell activation syndrome (MCAS)*
- Neurogenic bladder
- Ocular – 2024 - Retinal Drusen, 04/17/2025 – Epiretinal right eye
- Pancreas - Pancreatitis – first episode 2016 multiple episodes up through 2018 considered chronic (July 05, 2023 – severe atrophy, 4.5mm stone in neck, dilation of the pancreatic duct measuring up to 1cm in maximal diameter, small intraductal mass not completely excluded)
- Raynaud's syndrome
- Refeeding syndrome (no solid foods for months following GBCA injections – 40 lb weight loss)
- Sclerodactyly*
- Small-fiber neuropathy (SFN) – diagnosed 2018
Key to list above: *Symptoms appeared after DTPA Ca/Zn chelation.
The above list of my own associations tells a standalone story; creating curiosity.
The past eight years, after connecting the dots to gadolinium heavy metal deposition and toxicity has demonstrated and painted a visual board that is complex and concerning.
Doctors, often shaking their heads, are unable to offer a cure for anything on the list.
Instead, the solutions offered include long-term use of drugs, surgery, or other invasive protocols.
Debbie Heist Lambert - Bio
